NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.
Recent evidence suggests that sulfhydryl species can react with oxides of nitrogen under physiologic conditions and thereby stabilize endothelium-derived relaxing factor (EDRF) activity, but the presence of a specific in vivo thiol carrier for nitric oxide (NO) remains controversial. The single free...
Kaydedildi:
| Yayımlandı: | J Clin Invest |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Clinical Investigation
1993
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC288134/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8473501/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116364 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|